Nuveen Asset Management »

Outlook Therapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $339k 46k 7.38

More positions owned by Nuveen Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Nushares Etf Tr Get Opp Etf (NUGO)
Visa Com Cl A (V)

View all positions for Nuveen Asset Management

Top funds holding Outlook Therapeutics

Dr. Jeffrey R. Jay, M.D.
Tang Capital Management
BlackRock
Sphera Funds Management
Vanguard Group
Altium Capital Management
Caligan Partners
Schonfeld Strategic Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
LVW Advisors
Nuveen Asset Management
Susquehanna Fundamental Investments
Charles Schwab Investment Management

View all funds holding Outlook Therapeutics